BioLife Solutions, Inc. ( BLFS) - Key Metrics
BLFS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.39 | $0.07 | $0.10 | $0.06 |
| 2025Q3 | $0.59 | $0.01 | $0.13 | $0.06 |
| 2025Q2 | $0.53 | -$0.33 | $0.15 | $0.12 |
| 2025Q1 | $0.51 | -$0.01 | $0.04 | $0.03 |
BLFS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 81.66 |
| 2025Q3 | ? | 492.18 |
| 2025Q2 | ? | -16.25 |
| 2025Q1 | ? | -600.76 |
BLFS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.07% | ? |
| 2025Q4 | -0.83% | ? |
| 2025Q3 | 0.23% | ? |
| 2025Q2 | 0.55% | ? |
| 2025Q1 | 0.14% | ? |
BLFS
Price: $26.65
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.24 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 447300
Ebitda: -233997Market Capitalization: 1.3 billion